<!DOCTYPE html>
<html lang="en-us">

<head>
  <title>The next food marketing blitz is aimed at people on new weight-loss drugs | Ars Technica</title>
<script type="text/javascript">
  ars = {"ASSETS":"https:\/\/cdn.arstechnica.net\/wp-content\/themes\/ars\/assets","HOME_URL":"https:\/\/arstechnica.com","CIVIS":"\/civis","THEME":"light","VIEW":"grid","MOBILE":false,"SUBSCRIBER":false,"PLUS_PLUS":false,"LOGGED":false,"USER_ID":null,"ENV":"production","AD":{"tags":["daily-harvest","diet","food","food-industry","glp-1","gnc","mounjaro","nestle","ozempic","wegovy","weight-loss","weight-watchers","zepbound"],"channel":"science","slug":"with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods","template_type":"article","queue":[],"server":"production"},"TOTAL":112845,"UNREAD":0,"RECENT":[2026474,2026494,2026304,2025766,2026362,2026437,2026264,2025874,2025795,2026236,2026242,2026234,2025782,2026183,2026185,2026165,2026117,2025856,2026155,2026123,2026097,2026106,2025783,2025855,2026052],"LOGINS":true,"CROSS":false,"PARSELY":"arstechnica.com","COMMENTS":false,"HOMEPAGE":false,"SITE":1,"READY":[],"SHOW_ADS":true,"IMG_PROXY":"https:\/\/cdn.arstechnica.net\/i\/","CATEGORY":"science","PAGETITLE":"","ZEN_MODE":false,"MEMO_PID":"62012a7a19351c07620394e0"};
</script>
<link rel="stylesheet" type="text/css" media="all" href="https://cdn.arstechnica.net/wp-content/themes/ars/assets/css/main-1eae76c908.css" />
    <link rel="alternate" type="application/rss+xml" href="http://feeds.arstechnica.com/arstechnica/index" />
  <link rel="shortcut icon" href="https://cdn.arstechnica.net/favicon.ico" />
  <link rel="icon" type="image/x-icon" href="https://cdn.arstechnica.net/favicon.ico" />
  <link rel="apple-touch-icon" sizes="180x180" href="https://cdn.arstechnica.net/wp-content/themes/ars/assets/img/ars-ios-icon-d9a45f558c.png" />
  <link rel="mask-icon" href="https://cdn.arstechnica.net/wp-content/themes/ars/assets/img/ars-macos-safari-8997f76b21.svg" color="#ff4e00">
  <link rel="icon" sizes="192x192" href="https://cdn.arstechnica.net/wp-content/themes/ars/assets/img/material-ars-db41652381.png" />
  <link rel="me" href="https://mastodon.social/@arstechnica" />

    <meta name="application-name" content="Ars Technica"/>
  <meta name="msapplication-starturl" content="http://arstechnica.com/"/>
  <meta name="msapplication-tooltip" content="Ars Technica: Serving the technologist for 1.2 decades"/>
  <meta name="msapplication-task" content="name=News;action-uri=http://arstechnica.com/;icon-uri=https://cdn.arstechnica.net/favicon.ico"/>
  <meta name="msapplication-task" content="name=Features;action-uri=http://arstechnica.com/features/;icon-uri=https://cdn.arstechnica.net/ie-jump-menu/jump-features.ico"/>
  <meta name="msapplication-task" content="name=OpenForum;action-uri=http://arstechnica.com/civis/;icon-uri=https://cdn.arstechnica.net/ie-jump-menu/jump-forum.ico"/>
  <meta name="msapplication-task" content="name=Subscribe;action-uri=http://arstechnica.com/subscriptions/;icon-uri=https://cdn.arstechnica.net/ie-jump-menu/jump-subscribe.ico"/>


  <meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
  <meta name="advertising" content="ask" />
  <meta property="fb:admins" content="592156917" />
  <meta property="fb:admins" content="108943" />
  <meta property="fb:pages" content="19374573752" />

  <meta name="format-detection" content="telephone=no" />
  <meta name="theme-color" content="#000000" />

  
  <meta name="viewport" content="width=device-width,initial-scale=1">

  <!-- cache hit 53:single/meta:9fc5f12b422296f487d536c1e240e8e9 -->
<meta name='parsely-page' content='{"title":"The next food marketing blitz is aimed at people on new weight-loss drugs","link":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/","type":"post","author":"Beth Mole","post_id":2026494,"pub_date":"2024-05-23T14:08:53Z","section":"Science","tags":["daily-harvest","diet","food","food-industry","glp-1","gnc","mounjaro","nestle","ozempic","wegovy","weight-loss","weight-watchers","zepbound","type: report"],"image_url":"https:\/\/cdn.arstechnica.net\/wp-content\/uploads\/2024\/05\/GettyImages-1189380093-150x150.jpeg"}'>
<meta name='parsely-metadata' content='{"type":"report","title":"The next food marketing blitz is aimed at people on new weight-loss drugs","post_id":2026494,"lower_deck":"Taking a weight-loss drug? Food makers have just the new food for you.","image_url":"https:\/\/cdn.arstechnica.net\/wp-content\/uploads\/2024\/05\/GettyImages-1189380093-150x150.jpeg","listing_image_url":"https:\/\/cdn.arstechnica.net\/wp-content\/uploads\/2024\/05\/GettyImages-1189380093-360x200.jpeg"}'>

  <link rel="canonical" href="https://arstechnica.com/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/" />

<link rel="shorturl" href="https://arstechnica.com/?p=2026494" />

<meta name="description" content="Taking a weight-loss drug? Food makers have just the new food for you." />

<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:url" content="https://arstechnica.com/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/">
<meta name="twitter:title" content="The next food marketing blitz is aimed at people on new weight-loss drugs">
<meta name="twitter:description" content="Taking a weight-loss drug? Food makers have just the new food for you.">

<meta name="twitter:site" content="@arstechnica">
<meta name="twitter:domain" content="arstechnica.com">

<meta property="og:site_name" content="Ars Technica" />

<meta name="twitter:image:src" content="https://cdn.arstechnica.net/wp-content/uploads/2024/05/GettyImages-1189380093-760x380.jpeg">
  <meta name="twitter:image:width" content="760">
  <meta name="twitter:image:height" content="380">

  <meta name="twitter:creator" content="@BethMarieMole">

<meta property="og:url" content="https://arstechnica.com/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/" />
<meta property="og:title" content="The next food marketing blitz is aimed at people on new weight-loss drugs" />
<meta property="og:image" content="https://cdn.arstechnica.net/wp-content/uploads/2024/05/GettyImages-1189380093-760x380.jpeg" />
<meta property="og:description" content="Taking a weight-loss drug? Food makers have just the new food for you." />
<meta property="og:type" content="article" />
  <!-- cache hit 53:single/header:9fc5f12b422296f487d536c1e240e8e9 -->
        

<!-- OneTrust Cookies Consent Notice start -->
<script src="https://cdn.cookielaw.org/scripttemplates/otSDKStub.js" data-domain-script="b10882a1-8446-4e7d-bfb2-ce2c770ad910">
</script>
<script id="oneTrustScripts">
    window.OptanonWrapper = function() {
        var CCPAButton = document.getElementById('ot-sdk-btn');
        CCPAButton && CCPAButton.classList.add('ot-sdk-btn--visible');
        window.dataLayer && window.dataLayer.push({
            event: 'OneTrustGroupsUpdated'
        });
        window.cnBus && window.cnBus.emit('onetrust.OneTrustGroupsUpdated');
    };
</script>
<script src="https://cdn.cookielaw.org/opt-out/otCCPAiab.js" ccpa-opt-out-ids="C0002,C0003,C0004,C0005" ccpa-opt-out-geo="ca" ccpa-opt-out-lspa="true">
</script>
<!-- OneTrust Cookies Consent Notice end -->
<!-- Google Tag Manager DataLayer -->
<script>
window.dataLayer = window.dataLayer || [];
window.dataLayer.push({"event":"data-layer-loaded","user":{"ars_userId":undefined,"amg_userId":undefined,"uID":undefined,"sID":undefined,"loginStatus":false,"subscriberStatus":"none","infinityId":undefined,"registrationSource":undefined,"mdw_cnd_id":undefined,"monthlyVisits":undefined,"accessPaywall":undefined,"view":"grid","theme":"light","show_comments":false},"content":{"pageTemplate":"single","pageType":"article|report","contentCategory":"science","section":"science","subsection":undefined,"contributor":"Beth Mole","contentID":2026494,"contentLength":529,"display":"The next food marketing blitz is aimed at people on new weight-loss drugs","contentSource":"web","pageAssets":undefined,"uniqueContentCount":undefined,"monthlyContentCount":undefined,"publishDate":"2024-05-23T14:08:53-04:00","modifiedDate":"2024-05-23T14:20:24-04:00","keywords":"Daily Harvest|diet|food|food industry|GLP-1|GNC|mounjaro|nestle|Ozempic|wegovy|weight loss|Weight Watchers|zepbound","dataSource":undefined},"marketing":{"campaignName":undefined,"circCampaignId":undefined,"internalCampaignId":undefined,"brand":"Ars Technica","certified_mrc_data":undefined,"condeNastId":undefined},"page":{"pID":undefined,"syndicatorUrl":undefined,"pageURL":"https:\/\/arstechnica.com\/?p=2026494","canonical":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/","canonicalPathName":"\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/"},"search":{"facets":undefined,"searchTerms":undefined},"site":{"appVersion":"1.0.0"}});
</script>
<!-- End Google Tag Manager DataLayer -->
<!-- Google Tag Manager -->
<script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':
new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],
j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src=
'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);
})(window,document,'script','dataLayer','GTM-NLXNPCQ');</script>
<!-- End Google Tag Manager -->
<!-- Start Headline A/B -->
<script type="text/javascript">
  class ABTest {
    constructor(post_id, init_method) {
      this.post_id = post_id;
      this.ajaxurl = '/services/ars-ajax-handler.php';
      this.expireDays = 1 / 48; // 30 min
      this.group = this.getGroup();
      this.uid = this.getUid();
      this.init_method = init_method;
      this.setTitle();

      if (this.init_method === 'click') {
        this.click();
      } else {
        this.impression();
      }
    }

    setCookie(name, value, days) {
      var expires = "";
      if (days) {
        var date = new Date();
        date.setTime(date.getTime() + (days * 24 * 60 * 60 * 1000));
        expires = "; expires=" + date.toUTCString();
      }
      document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    getCookie(name) {
      var nameEQ = name + "=";
      var ca = document.cookie.split(';');
      for (var i = 0; i < ca.length; i++) {
        var c = ca[i];
        while (c.charAt(0) == ' ') c = c.substring(1, c.length);
        if (c.indexOf(nameEQ) == 0) return c.substring(nameEQ.length, c.length);
      }
      return null;
    }

    // Retrieves a unique id for determining whether the event should be recorded
    getUid() {
      var uid = this.getCookie('ars_ab_' + this.post_id + '_uid');
      if (!uid) {
        uid = (Math.random() + 1).toString(36).substring(2, 7);
        this.setCookie('ars_ab_' + this.post_id + '_uid', uid, this.expireDays);
      }
      return uid;
    };

    // Places the user in either A or B for this post id
    getGroup() {
      var group = this.getCookie('ars_ab_' + this.post_id + '_group');
      if (!group) {
        group = String.fromCharCode(Math.floor(Math.random() * 2) + 65).toLowerCase();
        this.setCookie('ars_ab_' + this.post_id + '_group', group, this.expireDays);
      }
      return group;
    };

    // Records a headline impression (from homepage or other listing)
    impression() {
      // Send fake ajax
      var params = {
        nonce: '60f9dc67db',
        action: 'ars_ab_impression',
        id: this.post_id,
        group: this.group,
        uid: this.uid,
        ts: (new Date()).getTime()
      };
      var url = this.ajaxurl + '?' + this.encodeParams(params);
      document.write('\x3Cscript type="text/javascript" src="' + url + '">\x3C/script>');
    };

    // Records a headline click from the actual post page
    click() {
      // Send fake ajax
      var params = {
        nonce: '0de21d8e2f',
        action: 'ars_ab_click',
        id: this.post_id,
        group: this.group,
        uid: this.uid,
        ts: (new Date()).getTime()
      };
      var url = this.ajaxurl + '?' + this.encodeParams(params);
      document.write('\x3Cscript type="text/javascript" src="' + url + '">\x3C/script>');
    };

    // If user is in B group, dynamically set title
    setTitle() {
      if (this.group == 'b') {
        var span = document.getElementById('ars_ab_' + this.post_id);
        var title = span.parentNode;
        title.innerHTML = span.getAttribute('data-title-b');
      }
    };

    encodeParams(data) {
      var ret = [];
      for (var d in data)
        ret.push(encodeURIComponent(d) + "=" + encodeURIComponent(data[d]));
      return ret.join("&");
    };

  };
</script>
<!-- End Headline A/B -->
<script>
  window.permutiveCohorts = {"cached_until":{"date":"2024-05-23 18:09:01.133621","timezone_type":3,"timezone":"UTC"},"cohorts":["bjfa"],"gam":["bjfa"],"xandr":[]};
  window.permutiveContextInfo = {"pageProperties":{"client":{"url":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/","referrer":"https:\/\/arstechnica.com\/","type":"web","user_agent":"Mozilla\/5.0 (Macintosh; Intel Mac OS X 10_15_7) AppleWebKit\/537.36 (KHTML, like Gecko) Chrome\/111.0.0.0 Safari\/537.36","domain":"arstechnica.com","title":"The next food marketing blitz is aimed at people on new weight-loss drugs &#8211; Ars Technica"},"type":"article","article":{"id":"2026494","category":"science","subcategory":"","title":"The next food marketing blitz is aimed at people on new weight-loss drugs","tags":["daily-harvest","diet","food","food-industry","glp-1","gnc","mounjaro","nestle","ozempic","wegovy","weight-loss","weight-watchers","zepbound"]}},"url":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/"};
</script>
<script src="https://www.googletagservices.com/tag/js/gpt.js" id="gpt-script" async></script>
<script>
  window.googletag = window.googletag || {};
  window.googletag.cmd = window.googletag.cmd || [];
  window.cns = window.cns || {};
  window.cns.queue = [];
  window.cns.async = function(s, c) {
    cns.queue.push({
      service: s,
      callback: c
    })
  };
</script>
<script>
  window.cns.pageContext = {"contentType":"article","templateType":"article","channel":"science","subChannel":"","slug":"with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods","server":"production","keywords":{"tags":["daily-harvest","diet","food","food-industry","glp-1","gnc","mounjaro","nestle","ozempic","wegovy","weight-loss","weight-watchers","zepbound"],"cm":[],"platform":["wordpress"],"copilotid":""}};
</script>
<script src="https://ads-static.conde.digital/production/cns/builds/ars-technica/ars-technica.min.js" async></script>
<script type="text/javascript" src="https://cdn.arstechnica.net/wp-content/themes/ars/assets/js/ars-dc1d08cbd8.ads.us.js"></script>
  <script type="text/javascript">!(function(o,_name){function n(){(n.q=n.q||[]).push(arguments)}n.v=1,o[_name]=o[_name]||n;!(function(o,t,n,c){function e(n){(function(){try{return(localStorage.getItem("v4ac1eiZr0")||"").split(",")[4]>0}catch(o){}return!1})()&&(n=o[t].pubads())&&n.setTargeting("admiral-engaged","true")}(c=o[t]=o[t]||{}).cmd=c.cmd||[],typeof c.pubads===n?e():typeof c.cmd.unshift===n?c.cmd.unshift(e):c.cmd.push(e)})(window,"googletag","function");})(window,String.fromCharCode(97,100,109,105,114,97,108));!(function(t,c,i){i=t.createElement(c),t=t.getElementsByTagName(c)[0],i.async=1,i.src="https://shiverscissors.com/v2fumwIJOo-LsCB0dlG18VSTW43CpWhUEPJuKeRTzrEQdSPPlMr5GymU",t.parentNode.insertBefore(i,t)})(document,"script");</script>

  <!-- Taboola -->
  <script type="text/javascript">
    window._taboola = window._taboola || [];
    _taboola.push({
      article: 'auto'
    });
    ! function(e, f, u, i) {
      if (!document.getElementById(i)) {
        e.async = 1;
        e.src = u;
        e.id = i;
        f.parentNode.insertBefore(e, f);
      }
    }(document.createElement('script'),
      document.getElementsByTagName('script')[0],
      '//cdn.taboola.com/libtrc/condenast1-network/loader.js',
      'tb_loader_script');
    if (window.performance && typeof window.performance.mark == 'function') {
      window.performance.mark('tbl_ic');
    }
  </script>
  <meta name='robots' content='max-image-preview:large' />
<link rel='dns-prefetch' href='//cdn.arstechnica.net' />
<link rel='dns-prefetch' href='//s.w.org' />
<link rel='dns-prefetch' href='//arstechnica-apps.s3.amazonaws.com' />
<link rel='stylesheet' id='wp-block-library-css'  href='https://cdn.arstechnica.net/wp/wp-includes/css/dist/block-library/style.min.css?ver=6.0.3' type='text/css' media='all' />
<style id='global-styles-inline-css' type='text/css'>
body{--wp--preset--color--black: #000000;--wp--preset--color--cyan-bluish-gray: #abb8c3;--wp--preset--color--white: #ffffff;--wp--preset--color--pale-pink: #f78da7;--wp--preset--color--vivid-red: #cf2e2e;--wp--preset--color--luminous-vivid-orange: #ff6900;--wp--preset--color--luminous-vivid-amber: #fcb900;--wp--preset--color--light-green-cyan: #7bdcb5;--wp--preset--color--vivid-green-cyan: #00d084;--wp--preset--color--pale-cyan-blue: #8ed1fc;--wp--preset--color--vivid-cyan-blue: #0693e3;--wp--preset--color--vivid-purple: #9b51e0;--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple: linear-gradient(135deg,rgba(6,147,227,1) 0%,rgb(155,81,224) 100%);--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan: linear-gradient(135deg,rgb(122,220,180) 0%,rgb(0,208,130) 100%);--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange: linear-gradient(135deg,rgba(252,185,0,1) 0%,rgba(255,105,0,1) 100%);--wp--preset--gradient--luminous-vivid-orange-to-vivid-red: linear-gradient(135deg,rgba(255,105,0,1) 0%,rgb(207,46,46) 100%);--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray: linear-gradient(135deg,rgb(238,238,238) 0%,rgb(169,184,195) 100%);--wp--preset--gradient--cool-to-warm-spectrum: linear-gradient(135deg,rgb(74,234,220) 0%,rgb(151,120,209) 20%,rgb(207,42,186) 40%,rgb(238,44,130) 60%,rgb(251,105,98) 80%,rgb(254,248,76) 100%);--wp--preset--gradient--blush-light-purple: linear-gradient(135deg,rgb(255,206,236) 0%,rgb(152,150,240) 100%);--wp--preset--gradient--blush-bordeaux: linear-gradient(135deg,rgb(254,205,165) 0%,rgb(254,45,45) 50%,rgb(107,0,62) 100%);--wp--preset--gradient--luminous-dusk: linear-gradient(135deg,rgb(255,203,112) 0%,rgb(199,81,192) 50%,rgb(65,88,208) 100%);--wp--preset--gradient--pale-ocean: linear-gradient(135deg,rgb(255,245,203) 0%,rgb(182,227,212) 50%,rgb(51,167,181) 100%);--wp--preset--gradient--electric-grass: linear-gradient(135deg,rgb(202,248,128) 0%,rgb(113,206,126) 100%);--wp--preset--gradient--midnight: linear-gradient(135deg,rgb(2,3,129) 0%,rgb(40,116,252) 100%);--wp--preset--duotone--dark-grayscale: url('#wp-duotone-dark-grayscale');--wp--preset--duotone--grayscale: url('#wp-duotone-grayscale');--wp--preset--duotone--purple-yellow: url('#wp-duotone-purple-yellow');--wp--preset--duotone--blue-red: url('#wp-duotone-blue-red');--wp--preset--duotone--midnight: url('#wp-duotone-midnight');--wp--preset--duotone--magenta-yellow: url('#wp-duotone-magenta-yellow');--wp--preset--duotone--purple-green: url('#wp-duotone-purple-green');--wp--preset--duotone--blue-orange: url('#wp-duotone-blue-orange');--wp--preset--font-size--small: 13px;--wp--preset--font-size--medium: 20px;--wp--preset--font-size--large: 36px;--wp--preset--font-size--x-large: 42px;}.has-black-color{color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-color{color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-color{color: var(--wp--preset--color--white) !important;}.has-pale-pink-color{color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-color{color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-color{color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-color{color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-color{color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-color{color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-color{color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-color{color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-color{color: var(--wp--preset--color--vivid-purple) !important;}.has-black-background-color{background-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-background-color{background-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-background-color{background-color: var(--wp--preset--color--white) !important;}.has-pale-pink-background-color{background-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-background-color{background-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-background-color{background-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-background-color{background-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-background-color{background-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-background-color{background-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-background-color{background-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-background-color{background-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-background-color{background-color: var(--wp--preset--color--vivid-purple) !important;}.has-black-border-color{border-color: var(--wp--preset--color--black) !important;}.has-cyan-bluish-gray-border-color{border-color: var(--wp--preset--color--cyan-bluish-gray) !important;}.has-white-border-color{border-color: var(--wp--preset--color--white) !important;}.has-pale-pink-border-color{border-color: var(--wp--preset--color--pale-pink) !important;}.has-vivid-red-border-color{border-color: var(--wp--preset--color--vivid-red) !important;}.has-luminous-vivid-orange-border-color{border-color: var(--wp--preset--color--luminous-vivid-orange) !important;}.has-luminous-vivid-amber-border-color{border-color: var(--wp--preset--color--luminous-vivid-amber) !important;}.has-light-green-cyan-border-color{border-color: var(--wp--preset--color--light-green-cyan) !important;}.has-vivid-green-cyan-border-color{border-color: var(--wp--preset--color--vivid-green-cyan) !important;}.has-pale-cyan-blue-border-color{border-color: var(--wp--preset--color--pale-cyan-blue) !important;}.has-vivid-cyan-blue-border-color{border-color: var(--wp--preset--color--vivid-cyan-blue) !important;}.has-vivid-purple-border-color{border-color: var(--wp--preset--color--vivid-purple) !important;}.has-vivid-cyan-blue-to-vivid-purple-gradient-background{background: var(--wp--preset--gradient--vivid-cyan-blue-to-vivid-purple) !important;}.has-light-green-cyan-to-vivid-green-cyan-gradient-background{background: var(--wp--preset--gradient--light-green-cyan-to-vivid-green-cyan) !important;}.has-luminous-vivid-amber-to-luminous-vivid-orange-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-amber-to-luminous-vivid-orange) !important;}.has-luminous-vivid-orange-to-vivid-red-gradient-background{background: var(--wp--preset--gradient--luminous-vivid-orange-to-vivid-red) !important;}.has-very-light-gray-to-cyan-bluish-gray-gradient-background{background: var(--wp--preset--gradient--very-light-gray-to-cyan-bluish-gray) !important;}.has-cool-to-warm-spectrum-gradient-background{background: var(--wp--preset--gradient--cool-to-warm-spectrum) !important;}.has-blush-light-purple-gradient-background{background: var(--wp--preset--gradient--blush-light-purple) !important;}.has-blush-bordeaux-gradient-background{background: var(--wp--preset--gradient--blush-bordeaux) !important;}.has-luminous-dusk-gradient-background{background: var(--wp--preset--gradient--luminous-dusk) !important;}.has-pale-ocean-gradient-background{background: var(--wp--preset--gradient--pale-ocean) !important;}.has-electric-grass-gradient-background{background: var(--wp--preset--gradient--electric-grass) !important;}.has-midnight-gradient-background{background: var(--wp--preset--gradient--midnight) !important;}.has-small-font-size{font-size: var(--wp--preset--font-size--small) !important;}.has-medium-font-size{font-size: var(--wp--preset--font-size--medium) !important;}.has-large-font-size{font-size: var(--wp--preset--font-size--large) !important;}.has-x-large-font-size{font-size: var(--wp--preset--font-size--x-large) !important;}
</style>
<link rel='stylesheet' id='article_forum_connect_comments-css'  href='https://cdn.arstechnica.net/wp-content/plugins/article-forum-connect/public/css/comments.css?ver=1.2.2' type='text/css' media='all' />
<link rel='stylesheet' id='article_forum_connect_paywall-css'  href='https://cdn.arstechnica.net/wp-content/plugins/article-forum-connect/public/css/paywall.css?ver=1.2.2' type='text/css' media='all' />
<meta property="article:published_time" content="2024-05-23T14:08:53+00:00">
<meta property="article:modified_time" content="2024-05-23T14:20:24+00:00">
<meta name="twitter:partner" content="tfwp" />
<!--
	generated 171 seconds ago
	generated in 0.263 seconds
	served from batcache in 0.002 seconds
	expires in 129 seconds
	billboard: forced 
	view: grid 
	theme: light 
 -->
</head>

<body class="post-template-default single single-post postid-2026494 single-format-standard grid-view light blog-us">
  <!-- Google Tag Manager (noscript) -->
<noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-NLXNPCQ" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>
<!-- End Google Tag Manager (noscript) -->

      	<aside class="ad ad_crown" aria-label="Top of page advertisement"></aside>
  
  <div class="site-wrapper">
    <a class="screen-reader-text skip-link" href="#main" aria-label="Skip to main content">Skip to main content</a>
    <header class="site-header">
      <div class="header-left">
        <a href="https://arstechnica.com" id="header-logo" title="Ars Technica Homepage">
      <span class="icon icon-logo-ars-us"></span>
  </a>
      </div>

      <div class="header-right">
        <nav id="header-nav-primary">
          <ul>
            
  <li><a class="nav-link section-information-technology " href="/information-technology/">Biz &amp; IT</a></li>
  <li><a class="nav-link section-gadgets " href="/gadgets/">Tech</a></li>
  <li><a class="nav-link section-science active" href="/science/">Science</a></li>
  <li><a class="nav-link section-tech-policy " href="/tech-policy/">Policy</a></li>
  <li><a class="nav-link section-cars " href="/cars/">Cars</a></li>
  <li><a class="nav-link section-gaming " href="/gaming/">Gaming &amp; Culture</a></li>
  <li><a class="nav-link store" href="/store/">Store</a></li>
  <li><a class="nav-link forums" href="/civis/">Forums</a></li>
          </ul>
        </nav>

                              <a href="/store/product/subscriptions/" class="header-highlight-link">Subscribe</a>
                                  <div class="dropdown" id="header-search">
          <a href="/search/" class="dropdown-toggle search-toggle" aria-label="Search" aria-expanded="false">
            <span class="icon icon-search-mag-glass"></span>
          </a>
          <div class="dropdown-content">
            <form action="/search/" method="GET" id="search_form">
  <input type="hidden" name="ie" value="UTF-8">
  <input type="text" name="q" id="hdr_search_input" value="" aria-label="Search..." placeholder="Search...">
</form>
<a class="nav-search-close">Close</a>
          </div>
        </div>
        <div class="dropdown dropdown-mega" id="header-burger">
          <a href="#site-menu" class="dropdown-toggle" aria-label="Menu" aria-expanded="false">
            <span></span>
          </a>
          <div id="site-menu" class="dropdown-content">
            <section class="burger-navigate">
  <h3>
    <span class="icon icon-half-target"></span>
    Navigate
  </h3>
  <ul>
          <li><a class="nav-link store" href="/store/">Store</a></li>
      <li><a class="nav-link subscribe" href="/store/product/subscriptions/">Subscribe</a></li>
        <li><a class="nav-link videos" href="http://video.arstechnica.com/">Videos</a></li>
    <li><a class="nav-link section-features" href="/features/">Features</a></li>
    <li><a class="nav-link section-reviews" href="/reviews/">Reviews</a></li>
  </ul>

  <ul>
    <li><a class="nav-link page-rss-feeds" href="/rss-feeds/">RSS Feeds</a></li>
    <li><a class="nav-link mobile" href="/?view=mobile">Mobile Site</a></li>
  </ul>

  <ul>
    <li><a class="nav-link page-about-us" href="/about-us/">About Ars</a></li>
    <li><a class="nav-link page-staff-directory" href="/staff-directory/">Staff Directory</a></li>
    <li><a class="nav-link page-contact-us" href="/contact-us/">Contact Us</a></li>
  </ul>

  <ul>
    <li><a class="nav-link page-advertise-with-us" href="https://advertising.condenast.com/brands/ars-technica">Advertise with Ars</a></li>
    <li><a class="nav-link page-reprints" href="/reprints/">Reprints</a></li>
  </ul>
</section>

<section class="burger-filter">
  <h3>
    <span class="icon icon-half-mag"></span>
    Filter by topic
  </h3>
  <ul id="burger-nav-primary">
    
  <li><a class="nav-link section-information-technology " href="/information-technology/">Biz &amp; IT</a></li>
  <li><a class="nav-link section-gadgets " href="/gadgets/">Tech</a></li>
  <li><a class="nav-link section-science active" href="/science/">Science</a></li>
  <li><a class="nav-link section-tech-policy " href="/tech-policy/">Policy</a></li>
  <li><a class="nav-link section-cars " href="/cars/">Cars</a></li>
  <li><a class="nav-link section-gaming " href="/gaming/">Gaming &amp; Culture</a></li>
  <li><a class="nav-link store" href="/store/">Store</a></li>
  <li><a class="nav-link forums" href="/civis/">Forums</a></li>
  </ul>
</section>

<section class="burger-settings">
  <h3>
    <span class="icon icon-half-gear"></span>
    Settings
  </h3>
  <div>
    <div class="burger-layout">
      
<p>Front page layout</p>
<div class="burger-layout-grid">
  <a rel="nofollow" href="/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?view=grid">
    <span class="icon icon-grid"></span><br>
    Grid
    <div class="faux-radio active"></div>
  </a>
</div>

<div class="burger-layout-list">
  <a rel="nofollow" href="/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?view=archive">
    <span class="icon icon-list"></span><br>
    List
    <div class="faux-radio "></div>
  </a>
</div>

    </div>
    <div class="burger-theme">
      <p>Site theme</p>
  <div class="burger-theme-light">
    <a rel="nofollow" href="/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?theme=light">
      <span><span>light</span></span>
      <div class="faux-radio active"></div>
    </a>
  </div>
  <div class="burger-theme-dark">
    <a rel="nofollow" href="/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?theme=dark">
      <span><span>dark</span></span>
      <div class="faux-radio "></div>
    </a>
  </div>
    </div>
  </div>
</section>
          </div>
        </div>
              <a class="navlink login-link" href="https://arstechnica.com/civis/login?_xfRedirect=%2Fscience%2F2024%2F05%2Fwith-weight-loss-drugs-booming-companies-target-dieters-with-new-foods%2F">
      Sign in
    </a>
  
        </div>
    </header>

              
    <main id="main" class="content-wrapper">

<script type="text/javascript">
  ars.ARTICLE = {"url":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/","short_url":"https:\/\/arstechnica.com\/?p=2026494","title":"The next food marketing blitz is aimed at people on new weight-loss drugs","author":509873,"authorName":"Beth Mole","pubDate":"2024-05-23T14:08:53Z","id":2026494,"topic":1500872,"pages":1,"current_page":1,"superscroll":true,"promoted":[],"single_page":false,"comments":46,"fullwidth":false,"slug":"with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods","arsStaff":{"104481":{"name":"Aaron Zimmerman","title":"Copy Chief","staff":true},"332715":{"name":"Andrew Cunningham","title":"Senior Technology Reporter","staff":true},"855306":{"name":"Ashley Belanger","title":"Senior Policy Reporter","staff":true},"1002":{"name":"Aurich Lawson","title":"Creative Director","staff":true},"857898":{"name":"Benj Edwards","title":"AI and Machine Learning Reporter","staff":true},"509873":{"name":"Beth Mole","title":"Senior Health Reporter","staff":true},"453791":{"name":"Cathleen O'Grady","title":"Contributing science reporter","staff":false},"102179":{"name":"Chris Lee","title":"Associate writer","staff":true},"329388":{"name":"Dan Goodin","title":"Security Editor","staff":true},"254631":{"name":"Diana Gitig","title":"Associate Writer","staff":false},"25862":{"name":"Eric Bangeman","title":"Managing Editor","staff":true},"512413":{"name":"Eric Berger","title":"Senior Space Editor","staff":true},"46707":{"name":"Iljitsch van Beijnum","title":"Associate Writer","staff":false},"316010":{"name":"Jason Marlin","title":"Technical Director","staff":true},"746799":{"name":"Jennifer Ouellette","title":"Senior Writer","staff":true},"15365":{"name":"Jeremy Reimer","title":"Senior Niche Technology Historian","staff":false},"52979":{"name":"John Timmer","title":"Senior Science Editor","staff":true},"312082":{"name":"Jon Brodkin","title":"Senior IT Reporter","staff":true},"14317":{"name":"Jonathan M. Gitlin","title":"Automotive Editor","staff":true},"998":{"name":"Ken Fisher","title":"Editor in Chief","staff":true},"440179":{"name":"Kerry Staurseth","title":"Associate Copyeditor","staff":true},"856780":{"name":"Kevin Purdy","title":"Senior Technology Reporter","staff":true},"328283":{"name":"Kyle Orland","title":"Senior Gaming Editor","staff":true},"10243":{"name":"Lee Hutchinson","title":"Senior Technology Editor","staff":true},"173191":{"name":"Matthew Lasar","title":"Associate writer","staff":true},"182268":{"name":"Nate Anderson","title":"Deputy Editor","staff":true},"1991":{"name":"Ohrmazd","title":"","staff":false},"391727":{"name":"Ron Amadeo","title":"Reviews Editor","staff":true},"588289":{"name":"Samuel Axon","title":"Senior Editor","staff":true},"294205":{"name":"Scott K. Johnson","title":"Associate Writer","staff":true},"173910":{"name":"Timothy B. Lee","title":"Senior tech policy reporter","staff":false}},"tags":["daily-harvest","diet","food","food-industry","glp-1","gnc","mounjaro","nestle","ozempic","wegovy","weight-loss","weight-watchers","zepbound"],"zen_mode":false};
</script>

<article itemscope itemtype="http://schema.org/NewsArticle" class="article-single standalone intro-standard " id="">
      <div class="column-wrapper">
    <div class="left-column">
        <header class="article-header">
            <h4 class="post-upperdek">
      GLP-1 friendly    &mdash;
</h4>
            <h1 itemprop="headline">The next food marketing blitz is aimed at people on new weight-loss drugs</h1>
            <h2 itemprop="description">Taking a weight-loss drug? Food makers have just the new food for you.</h2>
            <section class="post-meta">

  
<p class="byline" itemprop="author creator" itemscope itemtype="http://schema.org/Person">
      <a itemprop="url" href="https://arstechnica.com/author/beth/"  rel="author" ><span itemprop="name">Beth Mole</span></a>
    -    <time class="date" data-time="1716473333" datetime="2024-05-23T14:08:53+00:00">May 23, 2024 2:08 pm UTC</time>
</p>

  
</section>        </header>
        <section class="article-guts">
            <div itemprop="articleBody" class="article-content post-page">
                                    
<figure class="intro-image intro-left">
  <img src="https://cdn.arstechnica.net/wp-content/uploads/2024/05/GettyImages-1189380093-800x533.jpeg" alt="The next food marketing blitz is aimed at people on new weight-loss drugs">
      <figcaption class="caption"><div class="caption-text"><a href="https://cdn.arstechnica.net/wp-content/uploads/2024/05/GettyImages-1189380093-scaled.jpeg" class="enlarge-link" data-height="1706" data-width="2560">Enlarge</a></div><div class="caption-credit"><a rel="nofollow" class="caption-link" href="https://www.gettyimages.com/detail/news-photo/miami-beach-publix-grocery-store-frozen-foods-aisle-news-photo/1189380093?searchscope=image%2Cfilm&amp;adppopup=true">Getty | Jeffrey Greenberg</a></div></figcaption>  </figure>

  <aside id="social-left" class="social-left" aria-label="Read the comments or share this article">
          <a class="comment-count icon-comment-bubble-down" href="https://arstechnica.com/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?comments=1">
      <h4 class="comment-count-before">reader comments</h4>
  
  <span class="comment-count-number">46</span>
  </a>
        </aside>




<!-- cache hit 53:single/related:9fc5f12b422296f487d536c1e240e8e9 --><!-- empty -->
<p>As new diabetes and weight-loss drugs help patients curb appetites and <a href="https://arstechnica.com/science/2024/05/long-term-wegovy-study-finds-weight-loss-plateaus-a-little-after-a-year/">shed pounds</a>, food manufacturers are looking for new ways to keep their bottom lines plump.</p>
<p></p><div class="pullbox sidebar story-sidebar right"><div class="story-sidebar-part"><a href="https://arstechnica.com/science/2024/05/outrageously-priced-weight-loss-drugs-could-bankrupt-us-health-care/" class="recommendation-further-reading story-sidebar-part-img" style="background-image:url('https://cdn.arstechnica.net/wp-content/uploads/2024/05/GettyImages-2141945373-360x200.jpeg');" tabindex="-1" role="presentation" aria-hidden="true"></a><div class="story-sidebar-part-content"><h3>Further Reading</h3><a class="recommendation-further-reading" href="https://arstechnica.com/science/2024/05/outrageously-priced-weight-loss-drugs-could-bankrupt-us-health-care/">“Outrageously” priced weight-loss drugs could bankrupt US health care</a></div></div></div>Millions of Americans have begun taking the <a href="https://arstechnica.com/science/2024/05/outrageously-priced-weight-loss-drugs-could-bankrupt-us-health-care/">pricey new drugs</a>—particularly Mounjaro, Ozempic, Wegovy, and Zepbound—and millions more are expected to go on them in the coming years. As such, food makers are bracing for slimmer sales. In <a href="https://www.morganstanley.com/ideas/obesity-drugs-market-expanded-opportunity">a report earlier this month</a>, Morgan Stanley's tobacco and packaged food analyst Pamela Kaufman said the drugs are expected to affect both the amounts and the types of food people eat, taking a bite out of the food and drink industry's profits.
<p>"In Morgan Stanley Research surveys, people taking weight-loss drugs were found to eat less food in general, while half slashed their consumption of sugary drinks, alcohol, confections and salty snacks, and nearly a quarter stopped drinking alcohol completely," Kaufman said. Restaurants that sell unhealthy foods, particularly chains, may face long-term business risks, the report noted. Around 75 percent of survey respondents taking weight-loss drugs said they had cut back on going to pizza and fast food restaurants.</p>                                            <aside class="ad_wrapper" aria-label="In Content advertisement">
    <span class="ad_notice">Advertisement </span>    
    <div class="ad ad_instream"></div>    
</aside>
                                                        
<p>Some food makers aren't taking the threat lightly. On Tuesday, the massive multinational food and beverage conglomerate Nestlé announced a new line of frozen foods, called Vital Pursuit, <a href="https://www.nestleusa.com/media/pressreleases/vital-pursuit-glp-1-weight-management">aimed directly at people taking GLP-1 weight-loss drugs</a> (Wegovy and Ozempic). Nestlé—maker of DiGiorno frozen pizzas and Stouffer's frozen entrées—said the new product line will include frozen pizzas, sandwich melts, grain bowls, and pastas that are "portion-aligned to a weight loss medication user’s appetite." The frozen fare is otherwise said to contain fiber, "essential nutrients," and high protein, food features not specific for people on GLP-1 drugs.</p>
<p></p><div class="pullbox sidebar story-sidebar right"><div class="story-sidebar-part"><a href="https://arstechnica.com/science/2024/05/long-term-wegovy-study-finds-weight-loss-plateaus-a-little-after-a-year/" class="recommendation-further-reading story-sidebar-part-img" style="background-image:url('https://cdn.arstechnica.net/wp-content/uploads/2023/11/GettyImages-1692436787-360x200.jpeg');" tabindex="-1" role="presentation" aria-hidden="true"></a><div class="story-sidebar-part-content"><h3>Further Reading</h3><a class="recommendation-further-reading" href="https://arstechnica.com/science/2024/05/long-term-wegovy-study-finds-weight-loss-plateaus-a-little-after-a-year/">Weight loss from Wegovy sustained for up to four years, trial shows</a></div></div></div>"As the use of medications to support weight loss continues to rise, we see an opportunity to serve those consumers," Steve Presley, CEO of Nestlé North America, said in the product line announcement. "Vital Pursuit provides accessible, great-tasting food options that support the needs of consumers in this emerging category."
<p>Nestlé isn't alone. At the end of last year, WeightWatchers began offering <a href="https://www.weightwatchers.com/us/clinic/weight-loss-medication">a membership program</a> for people taking GLP-1 drugs. In January, meal delivery service Daily Harvest announced its "<a href="https://www.prnewswire.com/news-releases/daily-harvest-launches-january-jumpstart-program-to-help-people-achieve-new-years-health--wellness-goals-302027910.html">GLP-1 Companion Food Collection</a>." And last month, GNC announced a "<a href="https://www.gnc.com/learn/newsroom/gnc-semaglutide-support-program.html">GLP-1 support program</a>" for people on the drugs, which includes a collection of various supplements, coaching, and consultations.</p>
<p>The companies seem to be heeding the advice of analysts. Morgan Stanley's report noted that food makers can adapt to people's changing diets by "raising prices, offering 'better for you' or weight-management products, or catering to changing trends with vegan or low-sugar options." Kaufman noted that some companies are already adjusting by selling smaller packages and portions.</p>

                                                </div>

            
            
            
        </section>
    </div>
    <div class="xrail">
        <div class="xrail-content">
            
            
            
                            <div class="ars-interlude-container ad_xrail ad_xrail_top"></div>
            
            
                            <aside class="ad ad_xrail ad_xrail_top ad_xrail_last" aria-label="Top sidebar advertisement"></aside>
                    </div>
    </div>
</div>

<div class="column-wrapper">
    <div class="left-column">
        <div id="social-footer">
                  <a class="comment-count icon-comment-bubble-down" href="https://arstechnica.com/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?comments=1">
      <h4 class="comment-count-before">reader comments</h4>
  
  <span class="comment-count-number">46</span>
  </a>
          </div>
                    <!-- cache hit 53:single/author:e25d459d6a94dcd7c0e1f1ef4a380ce3 -->  <section class="article-author">
          <a style="background-image:url('https://cdn.arstechnica.net/wp-content/uploads/2016/05/b.mole-45957.jpg');" class="author-photo" href="/author/beth" tabindex="-1" role="presentation" aria-hidden="true"></a>
    
    <div class="author-bio">
      <section class="author-bio-top">
        <a href="/author/beth" class="author-name">Beth Mole</a>
        Beth is Ars Technica’s Senior Health Reporter. Beth has a Ph.D. in microbiology from the University of North Carolina at Chapel Hill and attended the Science Communication program at the University of California, Santa Cruz. She specializes in covering infectious diseases, public health, and microbes.      </section>
    </div>

  </section>
            </div>
    <div class="xrail"></div>
</div>
<div id="article-footer-wrap">
            <aside class="ad_wrapper" aria-label="Full width advertisement">
    <span class="ad_notice">Advertisement </span>        
    <div class="ad ad_fullwidth fullwidth"></div>
</aside>
    
            <section id="comments-area" class="comments-area column-wrapper">
      <div class="row comments-row left-column">
      <a name="comments-bar"></a>
      
<div class="wp-forum-connect-container">

    

    
</div>

    </div>
          <div class="xrail xrail-comments">
        <div class="xrail-content-wrapper">
          <div class="xrail-content xrail-content-comments">
            <aside class="ad ad_xrail ad_xrail_comments" aria-label="Comments sidebar advertisement"></aside>
          </div>
        </div>
                  <div class="xrail-content-wrapper xrail-content-wrapper-bottom">
            <div class="xrail-content xrail-content-comments">
              <aside class="ad ad_xrail ad_xrail_comments" aria-label="Comments sidebar advertisement"></aside>
            </div>
          </div>
              </div>
      </section>
                    <section class="inline-playlist">
  <div class='ars-video-playlist'>
    <h3 class="ars-video-playlist-module-header">Channel <span>Ars Technica</span></h3>
    <div class='ars-video-playlist-module' data-playlist-id='arstechnica-channel-ars-science' data-video-options='[]'></div>
  </div>
</section>
                <div class="prev-next-links">
  <a href="https://arstechnica.com/cars/2024/05/gm-to-recycle-10k-tons-of-ev-battery-materials-a-year-with-redwood-deal/" rel="prev"><span class="arrow">&larr;</span> Previous story</a>  <a href="https://arstechnica.com/cars/2024/05/teslas-can-still-be-stolen-with-a-cheap-radio-hack-despite-new-keyless-tech/" rel="next">Next story <span class="arrow">&rarr;</span></a></div>
        <footer id="article-footer">
  <div class="recommendations-footer">
    <div id="story-recommendations">
  <div class="heading-column">
    <h3>Related Stories</h3>
  </div>
  <ul id="story-recs" class="rec-wrap"></ul>
</div>
  </div>
      <div id="taboola-below-article-thumbnails---at"></div>
<script type="text/javascript">
  window._taboola = window._taboola || [];
  _taboola.push({
    mode: 'thumbnails-a-6x1',
    container: 'taboola-below-article-thumbnails---at',
    placement: 'Below Article Thumbnails - AT',
    target_type: 'mix'
  });
</script>
    <div class="recommendations-footer">
    <div id="latest-stories">
  <div class="heading-column">
    <h3>Today on Ars</h3>
  </div>
  <ul id="latest-recs" class="rec-wrap"></ul>
</div>
  </div>
</footer>
    </div>
  </article>
  </main>

  <footer class="site-footer">
    <nav class="nav-footer">

  <section>
    <ul>
      <li><a href="/store/">Store</a></li>
      <li><a href="/store/product/subscriptions/">Subscribe</a></li>
      <li><a href="/about-us/">About Us</a></li>
      <li><a href="/rss-feeds/">RSS Feeds</a></li>
      <li><a rel="nofollow" href="/science/2024/05/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods/?view=mobile">View Mobile Site</a></li>
    </ul>
  </section>

  <section>
    <ul>
      <li><a href="/contact-us/">Contact Us</a></li>
      <li><a href="/staff-directory/">Staff</a></li>
      <li><a href="https://advertising.condenast.com/brands/ars-technica">Advertise with us</a></li>
      <li><a href="/reprints/">Reprints</a></li>
    </ul>
  </section>

  <section class="footer-newsletter">
    <div class="newsletter-wrapper">
      <h3>
        <a href="/newsletters/" class="footer-newsletter-sign-up">Newsletter Signup</a>
      </h3>
      <p>Join the Ars Orbital Transmission mailing list to get weekly updates delivered to your inbox. <a href="/newsletters/" class="footer-newsletter-sign-up">Sign me up &rarr;</a></p>

      <div class="footer-social-links">
        <a href="https://twitter.com/arstechnica" class="footer-social-twitter">
          <svg style="height: 40px; width: 40px;" id="b" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 40 40">
            <defs>
              <clipPath id="e">
                <rect width="40" height="40" fill="none" />
              </clipPath>
              <clipPath id="f">
                <rect width="40" height="40" fill="none" />
              </clipPath>
            </defs>
            <g id="c">
              <g id="d">
                <g clip-path="url(#e)">
                  <g clip-path="url(#f)">
                    <path d="M16.3,28.1c7.5,0,11.7-6.3,11.7-11.7s0-.4,0-.5c.8-.6,1.5-1.3,2-2.1-.7,.3-1.5,.5-2.4,.6,.9-.5,1.5-1.3,1.8-2.3-.8,.5-1.7,.8-2.6,1-.6-.7-1.4-1.1-2.3-1.2s-1.8,0-2.6,.4c-.8,.4-1.4,1.1-1.8,1.9-.4,.8-.5,1.7-.3,2.6-1.6,0-3.2-.5-4.7-1.2-1.5-.7-2.7-1.8-3.8-3-.5,.9-.7,2-.5,3,.2,1,.9,1.9,1.7,2.5-.7,0-1.3-.2-1.9-.5h0c0,1,.3,1.9,.9,2.7,.6,.7,1.4,1.2,2.4,1.4-.6,.2-1.2,.2-1.9,0,.3,.8,.8,1.5,1.5,2s1.5,.8,2.4,.8c-1.5,1.1-3.2,1.8-5.1,1.8-.3,0-.7,0-1,0,1.9,1.2,4.1,1.8,6.3,1.8" fill="currentColor" />
                  </g>
                </g>
              </g>
            </g>
          </svg>
        </a>
        <a href="https://mastodon.social/@arstechnica" class="footer-social-mastodon">
          <svg style="height: 40px; width: 40px;" id="b" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 40 40">
            <defs>
              <clipPath id="e">
                <rect width="40" height="40" fill="none" />
              </clipPath>
              <clipPath id="f">
                <rect width="40" height="40" fill="none" />
              </clipPath>
            </defs>
            <g id="c">
              <g id="d">
                <g clip-path="url(#e)">
                  <g clip-path="url(#f)">
                    <path d="M29.3,16.6c0-4.3-2.8-5.6-2.8-5.6-1.4-.7-3.9-.9-6.5-1h0c-2.6,0-5,.3-6.4,1,0,0-2.8,1.3-2.8,5.6s0,2.2,0,3.4c.1,4.2,.8,8.4,4.7,9.5,1.8,.5,3.4,.6,4.6,.5,2.3-.1,3.5-.8,3.5-.8v-1.6c0,0-1.7,.5-3.5,.4-1.8,0-3.7-.2-4-2.4,0-.2,0-.4,0-.6,0,0,1.8,.4,4,.5,1.4,0,2.7,0,4-.2,2.5-.3,4.7-1.8,5-3.3,.4-2.2,.4-5.4,.4-5.4h0Zm-3.4,5.6h-2.1v-5.1c0-1.1-.5-1.6-1.4-1.6s-1.5,.6-1.5,1.9v2.8h-2.1v-2.8c0-1.3-.5-1.9-1.5-1.9s-1.4,.5-1.4,1.6v5.1h-2.1v-5.3c0-1.1,.3-1.9,.8-2.6,.6-.6,1.3-1,2.2-1s1.9,.4,2.4,1.2l.5,.9,.5-.9c.5-.8,1.3-1.2,2.4-1.2s1.7,.3,2.2,1c.6,.6,.8,1.5,.8,2.6v5.3Z" fill="currentColor" />
                  </g>
                </g>
              </g>
            </g>
          </svg>
        </a>
        <a href="https://www.facebook.com/arstechnica" class="footer-social-facebook">
          <svg style="height: 40px; width: 40px;" id="b" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 40 40">
            <defs>
              <clipPath id="e">
                <rect width="40" height="40" fill="none" />
              </clipPath>
              <clipPath id="f">
                <rect width="40" height="40" fill="none" />
              </clipPath>
            </defs>
            <g id="c">
              <g id="d">
                <g clip-path="url(#e)">
                  <g clip-path="url(#f)">
                    <path d="M17.3,13.9v2.8h-2v3.4h2v10h4.2v-10h2.8s.3-1.6,.4-3.4h-3.2v-2.3c0-.3,.5-.8,.9-.8h2.3v-3.5h-3.1c-4.4,0-4.3,3.4-4.3,3.9" fill="currentColor" />
                  </g>
                </g>
              </g>
            </g>
          </svg>
        </a>
        <a href="https://www.youtube.com/@arstechnica" class="footer-social-youtube">
          <svg style="height: 40px; width: 40px;" id="b" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 40 40">
            <defs>
              <clipPath id="e">
                <rect width="40" height="40" fill="none" />
              </clipPath>
              <clipPath id="f">
                <rect width="40" height="40" fill="none" />
              </clipPath>
            </defs>
            <g id="c">
              <g id="d">
                <g clip-path="url(#e)">
                  <g clip-path="url(#f)">
                    <path d="M29.6,15.2c-.1-.4-.3-.8-.6-1.1-.3-.3-.7-.5-1.1-.7-1.6-.4-7.8-.4-7.8-.4,0,0-6.3,0-7.8,.4-.4,.1-.8,.3-1.1,.7-.3,.3-.5,.7-.6,1.1-.4,1.6-.4,4.8-.4,4.8,0,0,0,3.3,.4,4.8,.1,.4,.3,.8,.6,1.1,.3,.3,.7,.5,1.1,.7,1.6,.4,7.8,.4,7.8,.4,0,0,6.3,0,7.8-.4,.4-.1,.8-.3,1.1-.7s.5-.7,.6-1.1c.4-1.6,.4-4.8,.4-4.8,0,0,0-3.3-.4-4.8m-11.6,7.8v-5.9l5.2,3-5.2,3Z" fill="currentColor" />
                  </g>
                </g>
              </g>
            </g>
          </svg>
        </a>
        <a href="https://www.instagram.com/arstechnica/" class="footer-social-instagram">
          <svg style="height: 40px; width: 40px;" id="b" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" viewBox="0 0 40 40">
            <defs>
              <clipPath id="e">
                <rect width="40" height="40" fill="none" />
              </clipPath>
              <clipPath id="f">
                <rect width="40" height="40" fill="none" />
              </clipPath>
            </defs>
            <g id="c">
              <g id="d">
                <g clip-path="url(#e)">
                  <g clip-path="url(#f)">
                    <path d="M20,10c2.7,0,3.1,0,4.1,0,1.1,0,1.8,.2,2.4,.5,.7,.3,1.2,.6,1.8,1.2,.6,.6,.9,1.1,1.2,1.8,.2,.6,.4,1.4,.5,2.4,0,1.1,0,1.4,0,4.1s0,3.1,0,4.1c0,1.1-.2,1.8-.5,2.4-.3,.7-.6,1.3-1.2,1.8-.6,.6-1.1,.9-1.8,1.2-.6,.2-1.4,.4-2.4,.5-1.1,0-1.4,0-4.1,0s-3.1,0-4.1,0c-1.1,0-1.8-.2-2.4-.5-.7-.3-1.3-.6-1.8-1.2-.5-.5-.9-1.1-1.2-1.8-.2-.6-.4-1.4-.5-2.4,0-1.1,0-1.4,0-4.1s0-3.1,0-4.1c0-1.1,.2-1.8,.5-2.4,.3-.7,.6-1.2,1.2-1.8,.6-.6,1.1-.9,1.8-1.2,.6-.2,1.4-.4,2.4-.5,1.1,0,1.4,0,4.1,0m0,2.5c-2.4,0-2.7,0-3.7,0-.9,0-1.4,.2-1.7,.3-.4,.1-.8,.4-1.1,.7-.3,.3-.5,.6-.7,1.1-.1,.3-.3,.8-.3,1.7,0,1,0,1.3,0,3.7s0,2.7,0,3.7c0,.9,.2,1.4,.3,1.7,.2,.4,.4,.7,.7,1.1,.3,.3,.6,.5,1.1,.7,.3,.1,.8,.3,1.7,.3,1,0,1.3,0,3.7,0s2.7,0,3.7,0c.9,0,1.4-.2,1.7-.3,.4-.2,.7-.4,1.1-.7,.3-.3,.5-.6,.7-1.1,.1-.3,.3-.8,.3-1.7,0-1,0-1.3,0-3.7s0-2.7,0-3.7c0-.9-.2-1.4-.3-1.7-.1-.4-.4-.8-.7-1.1-.3-.3-.7-.5-1.1-.7-.3-.1-.8-.3-1.7-.3-1,0-1.3,0-3.7,0m0,2.2c.7,0,1.4,.1,2,.4,.6,.3,1.2,.7,1.7,1.1,.5,.5,.9,1.1,1.1,1.7,.3,.6,.4,1.3,.4,2s-.1,1.4-.4,2c-.3,.6-.7,1.2-1.1,1.7-.5,.5-1.1,.9-1.7,1.1-.6,.3-1.3,.4-2,.4-1.4,0-2.7-.6-3.7-1.5-1-1-1.5-2.3-1.5-3.7s.6-2.7,1.5-3.7,2.3-1.5,3.7-1.5m0,8.3c.8,0,1.5-.3,2.1-.9,.6-.6,.9-1.3,.9-2.1s-.3-1.5-.9-2.1c-.6-.6-1.3-.9-2.1-.9s-1.5,.3-2.1,.9c-.6,.6-.9,1.3-.9,2.1s.3,1.5,.9,2.1c.6,.6,1.3,.9,2.1,.9m6.6-8.1c0,.4-.2,.7-.4,1s-.6,.4-1,.4-.7-.2-1-.4c-.3-.3-.4-.6-.4-1s.2-.7,.4-1c.3-.3,.6-.4,1-.4s.7,.2,1,.4c.3,.3,.4,.6,.4,1" fill="currentColor" />
                  </g>
                </g>
              </g>
            </g>
          </svg>
        </a>
      </div>

    </div>
  </section>
</nav>

<section class="footer-terms-logo">
  <div class="cn-logo">
    <a href="http://condenast.com/" class="icon icon-logo-cn-us" title="Visit Condé Nast"></a>
  </div>

  <p id="copyright-terms">
  CNMN Collection<br>
  WIRED Media Group<br>
  © 2024 Condé Nast. All rights reserved. Use of and/or registration on any portion of this site constitutes acceptance of our <a href="https://www.condenast.com/user-agreement/">User Agreement</a> (updated 1/1/20) and <a href="https://www.condenast.com/privacy-policy/">Privacy Policy and Cookie Statement</a> (updated 1/1/20) and <a href="/amendment-to-conde-nast-user-agreement-privacy-policy/">Ars Technica Addendum</a> (effective 8/21/2018). Ars may earn compensation on sales from links on this site. <a href="/affiliate-link-policy/">Read our affiliate link policy</a>.<br>
  <span style="display: inline-flex; flex-flow: row nowrap; align-items: center; gap: 5px;"><a href="https://www.condenast.com/privacy-policy/#california">Your California Privacy Rights</a> | <img src="https://cdn.arstechnica.net/wp-content/themes/ars/assets/img/privacyoptions123x59-c5c9972158.png" style="height: 1em; width: auto;" /> <a id="ot-sdk-btn" class="ot-sdk-show-settings">Do Not Sell My Personal Information</a></span><br>
  The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Condé Nast.<br>
  <a href="https://www.aboutads.info/">Ad Choices</a>
</p>
</section>
  </footer>
  </div>

  <script type="text/javascript" src="https://cdn.arstechnica.net/wp-content/themes/ars/assets/js/main-db925e406c.js"></script>


<!-- cache hit 53:single/javascript-footer:9fc5f12b422296f487d536c1e240e8e9 -->
        


    <!-- Taboola -->
  <script type="text/javascript">
    window._taboola = window._taboola || [];
    _taboola.push({
      flush: true
    });
  </script>

  <!-- Parse.ly start -->
<script type="text/plain" class="optanon-category-C0002" id="parsely-cfg" src="//fpa-cdn.arstechnica.com/keys/arstechnica.com/p.js"></script>
<!-- Parse.ly end -->

<!-- Memo start -->
<script type="text/javascript">
__memo_config = {
	pid: ars.MEMO_PID,
	url: ars.ARTICLE.url,
	author: [ars.ARTICLE.authorName],
	title: ars.ARTICLE.title,
	date: ars.ARTICLE.pubDate,
};
(function(){
	var s = document.createElement('script'); 
	s.async = true; 
	s.type = 'text/javascript'; 
	s.src = document.location.protocol + '//cdn.memo.co/js/memo.js';
	(document.getElementsByTagName('head')[0] || document.getElementsByTagName('body') [0]).appendChild(s); 
})();
</script>
<!-- Memo end -->

  
  
    
<script>
  (function() {
    var w = window.innerWidth ||
      document.documentElement.clientWidth ||
      document.body.clientWidth;
    var src = 'https://player.cnevids.com/interlude/arstechnica.js';
    if (!ars.MOBILE && w >= 1000) {
      src += '?isRightRail=true';
    }
    var s = document.createElement('script');
    s.setAttribute('async', true);
    s.setAttribute('src', src);
    document.body.appendChild(s);
  })();
</script>

<script id="conde-polar" src="https://cdn.mediavoice.com/nativeads/script/condenastcorporate/conde-asa-polar-master.js" async></script>
<script type="text/javascript" src="//s.skimresources.com/js/100098X1555750.skimlinks.js"></script>
<script type='text/javascript' id='snowplow-js-before'>
window.snowplowQueue = window.snowplowQueue || []; window.snowplowContexts = {"site":{"orgId":"4gKgcFGUFUvCGFzHakTPfYp85Yi8","orgAppId":null,"appVersion":null,"env":"production"},"content":{"functionalTags":null,"hasBuyButtons":null,"noOfRevisions":null,"editorNames":null,"author_name":"Beth Mole","contentId":"2026494","contentLength":1,"contentTitle":"The next food marketing blitz is aimed at people on new weight-loss drugs","contentSource":"web","authorIds":"45957","publishDate":"2024-05-23T14:08:53Z","modifiedDate":"2024-05-23T14:20:24Z","tags":"Daily Harvest|diet|food|food industry|GLP-1|GNC|mounjaro|nestle|Ozempic|wegovy|weight loss|Weight Watchers|zepbound","contentLang":"en-US","galleryName":null,"totalGalleryImages":null,"wordCount":446,"contentType":null,"templateType":"article_standard_two_column","primaryTag":null,"contentFlag":"news","isCommerceContent":null,"pageTypeProperties":null,"section":"science","subsection":null,"subsection2":null,"dataSource":"web","content_type":"article"},"syndication":{"content":null,"originalSource":null,"originalContentLanguage":null},"page":{"canonical":"https:\/\/arstechnica.com\/science\/2024\/05\/with-weight-loss-drugs-booming-companies-target-dieters-with-new-foods\/","syndicatorUrl":null},"user":{"amguuid":null}}; window.snowplowConfig = {"SNOWPLOW_COLLECTOR":"c.arstechnica.com","SNOWPLOW_SCRIPT":"https:\/\/globalservices.conde.digital\/p77xzrbz9z.js","AVO_API_KEY":"FTJO6mVPBIzdGhjn2Ruy","APP_ID":"ars-technica","APP_NAME":"ars-technica","APP_ENV":"production","APP_VERSION":"1.0.0","COOKIE_DOMAIN":".arstechnica.com"};
</script>
<script type='text/javascript' src='https://cdn.arstechnica.net/wp-content/mu-plugins/ars-snowplow/ars-snowplow-js/dist/main-1-0-4.js?ver=1.0.4' id='snowplow-js'></script>
<script type='text/javascript' src='https://cdn.arstechnica.net/wp-content/plugins/article-forum-connect/public/js/iframeResizer.min.js?ver=1.2.2' id='article_forum_connect_iframe_resizer-js'></script>
<script type='text/javascript' src='https://cdn.arstechnica.net/wp-content/plugins/article-forum-connect/public/js/iframe.js?ver=1.2.2' id='article_forum_connect_iframe-js'></script>
  </body>

  </html>